We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
(Medtronic) Risk of delays in the resumption of drug infusion and in logging of motor stall events after MRI scans. (MDA/2008/087)
(B Braun Melsungen AG and Fresenius Kabi Limited) Increased risk of renal dysfunction and mortality in critically ill or septic patients– class 1 action within 48 hours. (EL (13)A/18)
List of field safety notices (FSNs) from medical device manufacturers from 12 to 16 October 2015.
Collaboration agreement signed by UKAEA and Kyoto Fusioneering to advance materials for commercial fusion energy.
Some batches of gentamicin sulphate active pharmaceutical ingredient (API) used to manufacture gentamicin may contain higher than expected levels of histamine, which is a residual from the manufacturing process. Monitor patients for signs of histamine-related adverse reactions.
The UK Government is committing £220M to the conceptual design of a fusion power station – the Spherical Tokamak for Energy Production (STEP).
List of field safety notices (FSNs) from medical device manufacturers from 12 to 16 January 2015.
Summary List of field safety notices (FSNs) from medical device manufacturers from 3 - 7 October 2016
£880,000 of Innovate UK funding speeds development of 3D nanofibre filtration process for more cost-effective manufacture of enzymes
Do not use in children aged 16 years or less, except in specialist settings under expert medical supervision.
Steel cannula infusion sets manufactured by Unomedical should be checked due to small risk of needle breaking.
Caution in Use: Distribute to Hospital Pharmacy, Ward and Operating Theatre Level
List of field safety notices (FSNs) from medical device manufacturers from 7 to 11 September 2015.
Risk of accidental overdose, particularly in infants and neonates.
Macclesfield based distillery expects exports to grow tenfold after securing unprecedented pre-orders from Japanese customers for its new line of whisky.
(All brands) risk of back-tracking when an IV line has multiple access ports, which can lead to under-infusion or bolus delivery of IV drugs. (MDA/2010/073)
Incorrect dosage of bivalirudin in percutaneous coronary intervention can lead to major adverse cardiac events.
New maximum single intravenous dose of ondansetron for the management of chemotherapy-induced nausea and vomiting (CINV) restricted due to risk of QTc prolongation.
List of field safety notices (FSNs) from medical device manufacturers from 18 April to 22 April 2016
List of field safety notices (FSNs) from medical device manufacturers from 18 to 22 November 2019.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).